ARCHIVES

Nader Group Backs FDA In controversy Over Drug Testing

This article is from The Cancer Letter archive.

Vol. 03 No. 06 | February 11, 1977

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 9 Issue 3, Summer 1995

June 12, 1995

FDA Committee Approves Two NDAs, Blocks One, Hears NCI Toxicology Plan

June 15, 1979

In Brief: Carnegie Mellon President Emeritus honored By UPCI; Schiffer Leaves Maryland for Detroit

October 17, 1997

SBIR Solicitation Issued

September 13, 1996

Shorter, Simpler Consent Form Proposed For Phase I Trials

July 31, 2009

Study: Prostate Cancer Classifier Can Predict Risk Better Than PSA, Gleason Score, Tumor Stage

February 28, 2014